Reactivation of the Guardian of the Genome P53: A Promising Strategy for Treatment of Cancer.
作者信息
Abdel-Magid Ahmed F
机构信息
Therachem Research Medilab, LLC, 100 Jade Park, Chelsea, Alabama 35043, United States.
出版信息
ACS Med Chem Lett. 2021 Mar 1;12(3):331-333. doi: 10.1021/acsmedchemlett.1c00098. eCollection 2021 Mar 11.
Abstract
摘要
相似文献
1
Reactivation of the Guardian of the Genome P53: A Promising Strategy for Treatment of Cancer.基因组守护者P53的重新激活：一种有前景的癌症治疗策略。
ACS Med Chem Lett. 2021 Mar 1;12(3):331-333. doi: 10.1021/acsmedchemlett.1c00098. eCollection 2021 Mar 11.
2
Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome.p53肿瘤抑制因子的致癌突变：基因组守护者的恶魔
Cancer Res. 2000 Dec 15;60(24):6788-93.
3
p53: An Attractive Therapeutic Target for Cancer.p53：癌症治疗的有吸引力的靶点。
Curr Med Chem. 2020;27(22):3706-3734. doi: 10.2174/1573406415666190621094704.
4
Awakening the "guardian of genome": reactivation of mutant p53.唤醒“基因组守护者”：突变型 p53 的激活。
Cancer Chemother Pharmacol. 2019 Jan;83(1):1-15. doi: 10.1007/s00280-018-3701-x. Epub 2018 Oct 15.
5
Chemical Variations on the p53 Reactivation Theme.p53 再激活主题上的化学变化
Pharmaceuticals (Basel). 2016 May 13;9(2):25. doi: 10.3390/ph9020025.
6
Reactivation of p53 gene by MDM2 inhibitors: A novel therapy for cancer treatment.MDM2 抑制剂使 p53 基因重新激活：癌症治疗的新疗法。
Biomed Pharmacother. 2019 Jan;109:484-492. doi: 10.1016/j.biopha.2018.10.155. Epub 2018 Nov 6.
7
p73, the "assistant" guardian of the genome?p73，基因组的“助手”守护者？
Ann N Y Acad Sci. 2003 Dec;1010:9-15. doi: 10.1196/annals.1299.002.
8
Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome.p53对肿瘤血管生成的抑制作用：基因组守护者的新角色。
J Mol Med (Berl). 2007 Nov;85(11):1175-86. doi: 10.1007/s00109-007-0221-2. Epub 2007 Jun 23.
9
p53: guardian of the genome and policeman of the oncogenes.p53：基因组守护者与癌基因警察
Cell Cycle. 2007 May 2;6(9):1006-10. doi: 10.4161/cc.6.9.4211. Epub 2007 May 28.
10
Targeting p53 for Novel Anticancer Therapy.靶向 p53 用于新型抗癌疗法。
Transl Oncol. 2010 Feb;3(1):1-12. doi: 10.1593/tlo.09250.
引用本文的文献
1
Differential effect of plakoglobin in restoring the tumor suppressor activities of p53-R273H vs. p53-R175H mutants. plakoglobin 对 p53-R273H 与 p53-R175H 突变体肿瘤抑制活性的恢复作用存在差异。
PLoS One. 2024 Oct 3;19(10):e0306705. doi: 10.1371/journal.pone.0306705. eCollection 2024.
2
Nutri-PEITC Jelly Significantly Improves Progression-Free Survival and Quality of Life in Patients with Advanced Oral and Oropharyngeal Cancer: A Blinded Randomized Placebo-Controlled Trial.营养型姜黄素果冻可显著改善晚期口腔和口咽癌患者的无进展生存期和生活质量：一项双盲随机安慰剂对照试验。
Int J Mol Sci. 2023 Apr 25;24(9):7824. doi: 10.3390/ijms24097824.
3
Transition of amyloid/mutant p53 from tumor suppressor to an oncogene and therapeutic approaches to ameliorate metastasis and cancer stemness.淀粉样蛋白/突变型p53从肿瘤抑制因子向致癌基因的转变以及改善转移和癌症干性的治疗方法。
Cancer Cell Int. 2022 Dec 26;22(1):416. doi: 10.1186/s12935-022-02831-4.
本文引用的文献
1
Targeting the p53-MDM2 pathway for neuroblastoma therapy: Rays of hope.针对神经母细胞瘤治疗的 p53-MDM2 通路：希望之光。
Cancer Lett. 2021 Jan 1;496:16-29. doi: 10.1016/j.canlet.2020.09.023. Epub 2020 Sep 29.
2
Small-molecule MDM2/X inhibitors and PROTAC degraders for cancer therapy: advances and perspectives.用于癌症治疗的小分子MDM2/X抑制剂和PROTAC降解剂：进展与展望
Acta Pharm Sin B. 2020 Jul;10(7):1253-1278. doi: 10.1016/j.apsb.2020.01.003. Epub 2020 Jan 14.
3
Small-molecule modulation of p53 protein-protein interactions.小分子对 p53 蛋白-蛋白相互作用的调节。
Biol Chem. 2020 Jul 28;401(8):921-931. doi: 10.1515/hsz-2019-0405.
4
Restoring p53 in cancer: the promises and the challenges.恢复癌症中的p53：前景与挑战。
J Mol Cell Biol. 2019 Jul 19;11(7):615-619. doi: 10.1093/jmcb/mjz063.
5
p53: An Attractive Therapeutic Target for Cancer.p53：癌症治疗的有吸引力的靶点。
Curr Med Chem. 2020;27(22):3706-3734. doi: 10.2174/1573406415666190621094704.
6
The MDM2 gene amplification database.MDM2基因扩增数据库。
Nucleic Acids Res. 1998 Aug 1;26(15):3453-9. doi: 10.1093/nar/26.15.3453.
Zotero 插件